Press Releases from DelveInsight (457 total)
Corneal Ulcer Pipeline Insight 2025: 15+ Emerging Anti-Infective and Regenerativ …
DelveInsight's "Corneal Ulcer - Pipeline Insight, 2025" report offers a detailed overview of the therapeutic advancements underway for corneal ulcers, a serious ocular condition often…
Mesothelioma Pipeline Insight 2025: Emerging Immunotherapies and Targeted Agents …
DelveInsight's "Mesothelioma - Pipeline Insight, 2025" report offers a detailed overview of the clinical and developmental pipeline for mesothelioma-an aggressive and rare cancer primarily linked…
Galactosemia Pipeline Insight 2025: Novel Enzyme Replacement and mRNA Therapies …
DelveInsight's "Galactosemia - Pipeline Insight, 2025" report provides a comprehensive analysis of the evolving therapeutic landscape for galactosemia-a rare, inherited metabolic disorder caused by deficiencies…
Metachromatic Leukodystrophy Pipeline Insight 2025: Advancing Gene Therapies and …
DelveInsight's "Metachromatic Leukodystrophy - Pipeline Insight, 2025" report delivers a detailed overview of the therapeutic development landscape targeting this rare, inherited lysosomal storage disorder caused…
Genital Herpes Pipeline Insight 2025: Paving the Way for Long-Acting Therapies a …
DelveInsight's "Genital Herpes - Pipeline Insight, 2025" report offers an in-depth analysis of the evolving pipeline targeting this chronic, incurable viral infection caused primarily by…
Generalized Anxiety Disorder Pipeline Insight 2025: Advancing Beyond Benzodiazep …
DelveInsight's "Generalized Anxiety Disorder (GAD) - Pipeline Insight, 2025" report offers a deep dive into the emerging therapeutic landscape for GAD, a prevalent and often…
Meningitis Pipeline Insight, 2025: Advancing Preventive and Therapeutic Frontier …
DelveInsight's "Meningitis - Pipeline Insight, 2025" provides an in-depth analysis of the emerging therapies targeting bacterial, viral, and fungal forms of meningitis-an often life-threatening inflammation…
Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Pipeline Insight 2025: …
DelveInsight's "Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Pipeline Insight, 2025" offers a detailed assessment of the advancing treatment landscape for one of the most aggressive…
Metabolic Acidosis Pipeline Insight 2025: Exploring Next-Generation Therapies to …
DelveInsight's "Metabolic Acidosis - Pipeline Insight, 2025" report offers a comprehensive analysis of the evolving therapeutic landscape for metabolic acidosis, a serious electrolyte disorder characterized…
Metastatic Pancreatic Cancer Pipeline Insight 2025: Driving Innovation in One of …
DelveInsight's "Metastatic Pancreatic Cancer (MPC) - Pipeline Insight, 2025" report offers an in-depth analysis of the dynamic and challenging therapeutic landscape of metastatic pancreatic cancer,…
Limb Girdle Muscular Dystrophy Pipeline Insight 2025: Advancing Genetic and Rege …
DelveInsight's "Limb Girdle Muscular Dystrophy (LGMD) - Pipeline Insight, 2025" report provides a deep dive into the evolving therapeutic landscape of LGMD, a group of…
Hearing Loss Pipeline 2025: Groundbreaking Clinical Advancements by 30+ Global L …
With Hearing Loss reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Muscle Spasticity Pipeline Insight 2025: Advancing Neuromuscular Therapies for I …
DelveInsight's "Muscle Spasticity - Pipeline Insight, 2025" report offers a comprehensive evaluation of the drug development landscape targeting muscle spasticity across conditions such as multiple…
Multidrug-Resistant Gram-Negative Infections Pipeline Insight, 2025: Tackling Es …
DelveInsight's "Multidrug-Resistant Gram-Negative Infections - Pipeline Insight, 2025" report delivers an in-depth analysis of the dynamic R&D landscape targeting MDRGN pathogens such as Klebsiella pneumoniae,…
Moderate to Severe Plaque Psoriasis Pipeline Insight 2025: Advancing Biologic Fr …
DelveInsight's "Moderate to Severe Plaque Psoriasis - Pipeline Insight, 2025" report provides a comprehensive analysis of the drug development landscape for this chronic, immune-mediated skin…
Metastatic Uveal Melanoma Pipeline Insight, 2025: Tracking Targeted Innovation i …
DelveInsight's "Metastatic Uveal Melanoma (MUM) - Pipeline Insight, 2025" provides a detailed analysis of the clinical landscape for this rare and aggressive ocular cancer, spotlighting…
Methicillin-Resistant Staphylococcus Aureus Pipeline Insight 2025: Advancing Nov …
DelveInsight's "Methicillin-Resistant Staphylococcus Aureus (MRSA) - Pipeline Insight, 2025" report presents a comprehensive analysis of the evolving therapeutic landscape for MRSA infections, a major cause…
Myelodysplastic Syndrome Pipeline Insight 2025: Spotlighting 150+ Therapies Resh …
Myelodysplastic Syndromes are a group of heterogeneous hematologic malignancies characterized by ineffective hematopoiesis and risk of progression to acute myeloid leukemia (AML). Despite existing treatment…
Myocardial Infarction Pipeline Insight 2025: Advancing Cardiovascular Recovery w …
DelveInsight's "Myocardial Infarction - Pipeline Insight, 2025" provides an in-depth analysis of the evolving therapeutic landscape targeting heart tissue damage and ischemic injury. With over…
Nasal Polyps Pipeline Insight 2025: Unveiling the Future of Chronic Rhinosinusit …
DelveInsight's "Nasal Polyps - Pipeline Insight, 2025" report offers a detailed overview of the evolving pipeline landscape for nasal polyps, particularly chronic rhinosinusitis with nasal…
Checkpoint Inhibitors Competitive Landscape 2025: Tracking 60+ Immuno-Oncology A …
DelveInsight's "Checkpoint Inhibitors - Competitive Landscape, 2025" provides an in-depth analysis of the rapidly evolving immune checkpoint inhibitor (ICI) space, profiling 100+ companies and 150+…
Oligonucleotides Competitive Landscape 2025: 320+ Therapies Shaping the Future o …
DelveInsight's "Oligonucleotides - Competitive Landscape, 2025" report offers a deep dive into the global therapeutic race driven by oligonucleotide-based innovations. With over 280+ companies and…
Multiple Sclerosis Competitive Landscape, 2025: Over 75+ Assets Shaping the Futu …
DelveInsight's "Multiple Sclerosis - Competitive Landscape, 2025" offers a deep dive analysis into the evolving therapeutic ecosystem for this chronic autoimmune disorder of the central…
Glaucoma Competitive Landscape, 2025: Tracking 50+ Therapies Racing to Redefine …
DelveInsight's "Glaucoma - Competitive Landscape, 2025" report delivers a comprehensive evaluation of the global therapeutic competition shaping the future of glaucoma management. With over 45+…
HSV-1 Keratitis Competitive Landscape, 2025: Breaking Barriers in Herpetic Eye D …
DelveInsight's "HSV-1 Keratitis - Competitive Landscape, 2025" provides a comprehensive overview of 5+ companies and 5+ drug candidates actively shaping the treatment landscape for herpes…
Hypereosinophilic Syndrome Pipeline Insight 2025: Pioneering Precision Approache …
Hypereosinophilic Syndrome (HES) is a rare group of disorders characterized by persistently elevated eosinophil levels, often leading to end-organ damage affecting the heart, lungs, skin,…
House Dust Mite Allergy - Pipeline Insight, 2025: Redefining Allergen Immunother …
House dust mite (HDM) allergy is a leading cause of perennial allergic rhinitis and asthma worldwide, affecting millions of individuals and significantly impairing quality of…
Pancreatic Cancer Pipeline Insight 2025: Breaking Barriers with Novel Targets an …
Pancreatic cancer remains one of the deadliest malignancies globally, with a 5-year survival rate lingering in the single digits due to late diagnosis, rapid disease…
TCR Therapy Pipeline Insight 2025: Targeting Intracellular Tumor Antigens with U …
T-cell receptor (TCR) therapy represents a next-generation cell-based immunotherapy that unlocks access to intracellular tumor antigens presented via MHC molecules, overcoming limitations of conventional CAR-T…
Angiopoietin-2 (Ang-2) Inhibitor Pipeline Insight 2025: Targeting Vascular Desta …
Angiopoietin-2 (Ang-2) is a critical regulator of vascular remodeling and destabilization, playing a central role in pathological angiogenesis and inflammation. Elevated Ang-2 levels are associated…
Global Contract Development and Manufacturing Organization (CDMO) Market to Reac …
The global CDMO market is witnessing sustained growth, propelled by the rising trend of pharmaceutical and biotech companies outsourcing development and manufacturing operations to enhance…
Opioid Dependence Pipeline Insight 2025: Innovating Beyond Maintenance Therapy T …
Opioid dependence remains a persistent public health crisis, contributing to high rates of overdose, relapse, and mortality worldwide. While current treatment strategies-such as opioid agonist…
Diabetic Neuropathy - Pipeline Insight, 2025: Pioneering Disease-Modifying Thera …
Diabetic neuropathy, one of the most prevalent and debilitating complications of diabetes, affects nearly half of all diabetic patients over time, leading to chronic pain,…
Neurotrophic Keratitis Pipeline Insight 2025: Targeting Corneal Healing and Nerv …
Neurotrophic keratitis (NK), a rare degenerative corneal disease caused by trigeminal nerve dysfunction, poses significant challenges in ophthalmic care due to its chronic, progressive nature…
Pulmonary Hypertension - Pipeline Insight, 2025: Unlocking Novel Mechanisms to A …
Pulmonary Hypertension (PH), a complex and progressive disorder characterized by elevated pulmonary arterial pressure and vascular resistance, often leads to right heart failure and reduced…
Glaucoma - Pipeline Insight, 2025: Advancing Beyond IOP Control Toward Neuroprot …
Glaucoma, a leading cause of irreversible blindness worldwide, is traditionally managed through therapies that lower intraocular pressure (IOP). However, as understanding of the disease evolves,…
Gene Therapy Market to Grow at a CAGR of 19.25% Through 2032, Driven by Breakthr …
The global gene therapy market is on a strong upward trajectory, fueled by scientific advancements, growing approvals, and rising demand for personalized and curative treatments.…
Global Spinal Implants Market to Grow at a CAGR of 5.50% Through 2032, Fueled by …
The spinal implants market is steadily expanding, driven by the increasing prevalence of degenerative spinal conditions, spinal injuries, deformities, and age-related disorders such as osteoporosis.…
Myelofibrosis - Pipeline Insight, 2025: Novel Disease-Modifying Therapies Target …
Myelofibrosis, a rare and chronic myeloproliferative neoplasm, is characterized by bone marrow fibrosis, abnormal blood cell production, and splenomegaly. Historically treated with symptom-focused therapies, the…
Thalassemia - Pipeline Insight, 2025: Advancing Curative and Disease-Modifying T …
Thalassemia, a group of inherited blood disorders characterized by defective hemoglobin synthesis, continues to pose significant clinical challenges despite existing transfusion and iron chelation therapies.…
Severe Hypertriglyceridemia (SHTG) - Pipeline Insight, 2025: Emerging Therapies …
Severe Hypertriglyceridemia (SHTG), characterized by triglyceride levels exceeding 500 mg/dL, significantly elevates the risk of acute pancreatitis and cardiovascular complications. Despite the availability of fibrates,…
Global Vascular Stents Market to Grow at a CAGR of 6.35% Through 2032, Driven by …
The vascular stents market is set for sustained growth through 2032, propelled by the rising prevalence of cardiovascular diseases (CVDs), the global aging population, and…
Global Vascular Grafts Market to Grow at a CAGR of 6.86% Through 2032, Driven by …
The vascular grafts market is witnessing steady growth, propelled by the rising incidence of cardiovascular diseases, aneurysms, and peripheral artery disease (PAD) across aging populations…
Wilson Disease - Pipeline Insight, 2025: Advancing Therapies Targeting Copper Me …
Wilson disease, a rare autosomal recessive disorder caused by mutations in the ATP7B gene, leads to abnormal copper accumulation in the liver, brain, and other…
Leishmaniasis - Pipeline Insight, 2025: Advancing Antiparasitic Innovation Amids …
Leishmaniasis, a neglected tropical disease caused by protozoan parasites of the genus Leishmania, remains a serious global health concern, especially in endemic regions across Asia,…
Acute Coronary Syndrome - Pipeline Insight, 2025: Targeted Therapies and Cardiop …
Acute Coronary Syndrome (ACS), a life-threatening manifestation of coronary artery disease encompassing unstable angina, NSTEMI, and STEMI, continues to be a major global health burden.…
Tau Inhibitors - Pipeline Insight, 2025: Targeting Tau Pathology to Transform Ne …
Tau protein aggregation is increasingly recognized as a central driver of neuronal dysfunction in Alzheimer's disease and related tauopathies. With amyloid-directed therapies facing challenges, tau-targeting…
Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2025: Advancing …
Dementia associated with Alzheimer's disease (AD) remains a high-burden neurodegenerative condition, with limited disease-modifying therapies approved to date. However, 2025 marks a turning point, as…
Pruritus - Pipeline Insight, 2025: Novel Anti-itch Pathways Emerge as Biotech an …
Pruritus (chronic itch), a common symptom across dermatologic, hepatic, and renal conditions, is gaining recognition as a standalone therapeutic target. With existing treatments offering only…
Global Surgical Robotic Systems Market to Expand at a CAGR of 13.21% Through 203 …
The surgical robotic systems market is witnessing a dynamic shift, driven by the increasing demand for precision, control, and minimally invasive surgical solutions. With a…
